Literature DB >> 19224785

Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer.

Tero Varpula1, Janne Rapola, Marko Sallisalmi, Jouni Kurola.   

Abstract

Calcium channel blocker (CCB) overdose is often lethal. Conventional medical treatment includes i.v. calcium, high doses of catecholamines, insulin, and glucagon. A new inotropic drug, levosimendan, should be considered in severe CCB poisoning. Levosimendan's pharmacologic features differ from other inotropic drugs. It is a calcium sensitizer and improves contraction without increasing intracytosolic calcium concentration. We describe two patients with serious CCB overdose. Despite intensive medical and mechanical cardiovascular support, both patients remained in shock. Hemodynamics gradually improved after administration of levosimendan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224785     DOI: 10.1213/ane.0b013e3181931737

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Life-threatening calcium channel blocker overdose and its management.

Authors:  Imran Rizvi; Ajaz Ahmad; Ankush Gupta; Shamsuz Zaman
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Successful treatment with integrated Chinese and western medicine for severe overdose of amlodipine: A case report.

Authors:  Fang Lai; Yan Zhang; Dong-Ping Xie; Fang Li; Yun Han
Journal:  Chin J Integr Med       Date:  2015-04-14       Impact factor: 1.978

3.  Massive calcium channel blocker overdose: intravenous insulin and glucose as a therapy.

Authors:  Gareth Rosser; Simon William Dubrey
Journal:  BMJ Case Rep       Date:  2012-06-05

4.  Amlodipine poisioning complicated with acute non-cardiogenic pulmonary oedema.

Authors:  Ruairi Hasson; Victoria Mulcahy; Hasan Tahir
Journal:  BMJ Case Rep       Date:  2011-09-04

5.  Levosimendan as treatment option in severe verapamil intoxication: a case report and review of the literature.

Authors:  Mirjam Osthoff; Christine Bernsmeier; Stephan C Marsch; Patrick R Hunziker
Journal:  Case Rep Med       Date:  2010-08-11

6.  Effect of levosimendan in experimental verapamil-induced myocardial depression.

Authors:  Jouni Kurola; Heli Leppikangas; Jarkko Magga; Leena Lindgren; Vesa Kiviniemi; Juha Rutanen; Esko Ruokonen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-03-11       Impact factor: 2.953

7.  Treatment of amlodipine overdose.

Authors:  Hossein Sanaei-Zadeh
Journal:  Indian J Crit Care Med       Date:  2012-07

8.  The use of extracorporeal life support in adolescent amlodipine overdose.

Authors:  Elizabeth A Persad; Lakshmi Raman; Marita T Thompson; Paul W Sheeran
Journal:  Indian J Crit Care Med       Date:  2012-10

Review 9.  Levosimendan: current data, clinical use and future development.

Authors:  M S Nieminen; S Fruhwald; L M A Heunks; P K Suominen; A C Gordon; M Kivikko; P Pollesello
Journal:  Heart Lung Vessel       Date:  2013

Review 10.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.